Skip to main content

2025 Canadian Cardiovascular Congress Main banner

258 Views

Session Evaluation

Electrophysiology

Imaging

Cardiology

Clinical Research

Session Type: Multi-Discipline Session

246 - CHRS / CSCMRI / CSE WORKSHOP- MITRAL VALVE PROLAPSE: WHEN SHOULD I WORRY?

Friday, October 24, 2025

2:00pm - 3:00pm ET

Room:303AB

Target Audience: General: All cardiovascular (clinical and research) health professionals, Electrophysiologists, Magnetic imaging specialist

Co-Chair(s)

Amer Johri, MD (he/him/his)

Professor
CSE
Queen's University
Isabelle Nault, MD (she/her/hers)

Cardiologist
IUCPQ
Université Laval
MC

Michael Chetrit, MD

Cardiologist
McGill University Health Centre Research Institute
McGill University

Presenter(s)

Léna Rivard, MD,MSc (she/her/hers)

Associate Professor
Institut de Cardiologie de Montréal
Montreal Heart Institute
IR

Idan Roifman, Director of Non-invasive Cardiology and Multimodality Imaging, Reichmann Family Chair for Cardiovascular Research

Cardiologist
CSCMRI
University of Toronto
Maxime Tremblay-Gravel, MD MSc (he/him/his)

Cardiologist
Institut de Cardiologie de Montréal
Université de Montréal

Early Career(s)

Maxime Tremblay-Gravel, MD MSc (he/him/his)

Cardiologist
Institut de Cardiologie de Montréal
Université de Montréal

Planning Committee Member(s)

Laroussi Leila, MD (she/her/hers)

Cardiologist
CIUSSS du Nord de l’île de Montréal
Université de Montréal
Léna Rivard, MD,MSc (she/her/hers)

Associate Professor
Institut de Cardiologie de Montréal
Montreal Heart Institute
Maxime Tremblay-Gravel, MD MSc (he/him/his)

Cardiologist
Institut de Cardiologie de Montréal
Université de Montréal

Learning Objectives:

At the end of this session participants will be able to:

to discuss the clinical features associated with an increased risk of sudden cardiac death (SCD) in mitral valve prolapse (MVP);
review new echographic criteria of malignant MVP; and
review new imaging technology that have, recently, been developed to stratify MVP.